Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy.
临床药物筛选显示,氯法齐明可增强抗 PD-1 和 CTLA-4 免疫疗法的疗效,同时降低其毒性
期刊:Cancer Cell
影响因子:44.5
doi:10.1016/j.ccell.2024.03.001
Xue Gang, Li Xin, Kalim Muhammad, Fang Jing, Jiang Zhiwu, Zheng Ningbo, Wang Ziyu, Li Xiaoyin, Abdelrahim Maen, He Zhiheng, Nikiforov Mikhail, Jin Guangxu, Lu Yong